Cargando…
Dendritic cell-glioma fusion activates T lymphocytes by elevating cytotoxic efficiency as an antitumor vaccine
BACKGROUND: Hybrid cells produced by fusions of tumor and dendritic cells (DC) have demonstrated remarkable efficacy for priming the anti-tumor immune response. In the current study, we examined the antitumor activity of cytotoxic T lymphocytes (CTLs) primed in response to a tumor vaccine comprising...
Autores principales: | Tian, Fuming, Dou, Changwu, Qi, Songtao, Chen, Bo, Zhao, Liqun, Wang, Xiaojuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439993/ https://www.ncbi.nlm.nih.gov/pubmed/26155134 http://dx.doi.org/10.5114/ceji.2014.45935 |
Ejemplares similares
-
Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells
por: Koido, Shigeo, et al.
Publicado: (2010) -
Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes
por: Koido, Shigeo, et al.
Publicado: (2013) -
Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma
por: Wu, Zhe Bao, et al.
Publicado: (2014) -
Carthamus tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes
por: Chang, Jia-Ming, et al.
Publicado: (2011) -
A novel CTLA-4 blocking strategy based on nanobody enhances the activity of dendritic cell vaccine-stimulated antitumor cytotoxic T lymphocytes
por: Yang, Wenli, et al.
Publicado: (2023)